An interventional study of Early bilateral rectus sheat block and Late bilateral rectus sheat block in Prostate Cancer, Pain Management and Nociception Level Index(NoL), sponsored by Koc University Hospital. Completed at 1 site in Turkey (Türkiye). Open to male participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-03.
Sponsored by Koc University Hospital · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 111 studies in Prostatic Neoplasms with a site in Turkey — 22 open to participants now, 42 under way, 21 of them phase 3. Prostatic Neoplasms · Turkey.
Among the 111 studies in Prostatic Neoplasms with a site in Turkey, this one is the 78th largest by enrollment of the 90 interventional ones that give a count, is one of 13 that started in 2026, is one of 40 with no phase, and was the 94th registered.
7,058 studies on the registry are indexed under Prostatic Neoplasms; 1,582 are open to participants now.
Browse Prostatic Neoplasms studies →22 of the 111 studies in Prostatic Neoplasms with a site in Turkey are open now. Recruiting first, the newest first:
Marmara University Pendik Training and Research Hospital · Sites in Turkey
Ages 18–75 · Men only
AstraZeneca · Sites in Turkey, United States, Austria and 18 more countries
Ages 18+ · Men only
Ankara Etlik City Hospital · Sites in Turkey
Ages 50–75 · Men only
AstraZeneca · Sites in Turkey, United States, Australia and 21 more countries
Ages 18+ · Men only
Giresun University · Sites in Turkey
Ages 18+ · Men only
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 1,236 Prostatic Neoplasms studies recruiting now, 933 (75%) set no upper age limit and 77 (6%) stop at 75 or younger; 67 take children under 18; 82 take healthy volunteers.
This study: 18 Years and older · male · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
111 studies; the count open now beside each. This study's row is marked.
First in 1997; this study’s year is marked. 13 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 50 is below the median of 60 across 5,358 interventional studies indexed under Prostatic Neoplasms.
Median enrollment 226 across the 90 interventional studies, 230 across the 21 observational. Of the 64 that completed or were terminated, 19 (30%) have results posted.
This tab as a report to print or save as PDF → With an account.
49 of 111 have an industry lead sponsor. The 10 most frequent:
Koc University Hospital is the lead sponsor of 11 studies on the registry; 3 are open to participants now.
Koc University Hospital has 1 study filed under Prostatic Neoplasms — fewer than ten, so there is no comparison to draw.
10 of the studies in Prostatic Neoplasms with a site in Turkey that are under way reach primary completion within a year, 4 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06551324Phase 3PfizerA Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1). | 2027-02-28 |
| NCT02531516Phase 3Aragon Pharmaceuticals, Inc.An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS | 2027-03-01 |
| NCT06120491Phase 3AstraZenecaSaruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents | 2027-09-30 |
| NCT06629779Phase 3PfizerA Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer. | 2027-09-30 |
| NCT07491198Ege UniversityEffect Of Trendelenburg Position And Pneumoperitoneum On Optic Nerve Sheath Diameter In Robot-Assisted Prostatectomy | 2026-12-01 |
Add all 10 to your calendar (.ics) → With an account.
Among the 111 studies in Prostatic Neoplasms with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The aim of this study is to observe the effect of administering local anesthetic to the abdominal wall at the beginning or end of surgery under general anesthesia on opioid consumption during surgery. The hypothesis of this study is to demonstrate that administering a rectus sheath block before the surgical procedure under general anesthesia is effective in reducing intraoperative opioid consumption and opioid-related side effects compared to administering it after the surgery is completed.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
-ASA () I-III adult patients with prostate cancer and benign prostate diseases scheduled for robotic surgery at Koç University Hospital.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The group of patients undergoing robotic prostatectomy surgery who received a rectus sheath block prior to the surgical procedure
Procedure: Early bilateral rectus sheat block
The group of patients undergoing robotic prostatectomy surgery who received a rectus sheath block after the surgical procedure
Procedure: Late bilateral rectus sheat block
Bilateral rectus sheat block will be performed after the anesthesia induction, before the start of the surgery
Bilateral rectus sheat block will be performed after the completion of the surgery, before the end of general anesthesia
Total intraoperatif remifentanil consumption
Time frame: Total operative duration
Average intraoperative remifentanil consumption
Total intraoperative remifentail consumption divided by the weight of the patient (kg) and total operative duration (minutes). (mcg/kg/dk)
Time frame: Total operative duration
Cumulative opioid consumption at postoperative 1st hour
Cumulative opioid consumption at postoperative 1st hour in IV morphine equivalent
Time frame: From the end of the surgery to the end of the first postoperative hour
Cumulative opioid consumption at postoperative 6th hour
Cumulative opioid consumption at postoperative 6th hour in IV morphine equivalent
Time frame: From the end of the surgery to the end of the 6th postoperative hour
Cumulative opioid consumption at postoperative 12th hour
Cumulative opioid consumption at postoperative 12th hour in IV morphine equivalent
Time frame: From the end of the surgery to the end of the 12th postoperative hour
Cumulative opioid consumption at postoperative 24th hour
Cumulative opioid consumption at postoperative 24th hour in IV morphine equivalent
Time frame: From the end of the surgery to the end of the 24th postoperative hour
Pain at postoperative first hour
Pain measured by Numeric Rating Scale (0-10)
Time frame: At the end of the postoperative 1st hour
Pain at postoperative 6th hour
Pain measured by Numeric Rating Scale (0-10)
Time frame: At the end of the postoperative 6th hour
Pain at postoperative 12th hour
Pain measured by Numeric Rating Scale (0-10)
Time frame: At the end of the postoperative 12th hour
Pain at postoperative f24th hour
Pain measured by Numeric Rating Scale (0-10)
Time frame: At the end of the postoperative 24th hour
Rescue analgesia
Total rescue fentanyl administered (mcg)
Time frame: From the end of the surgery to the end of the first postoperative hour
Patient satisfaction
Patient satisfaction reported by the patient in a scale from 1 to 5
Time frame: At the end of the 24th postoperative hour
Plan to share: No — Individual participant data will not be publicly available. De-identified data may be shared upon reasonable request to the corresponding author, subject to institutional approval and a data use agreement.
Ran from Mar 2026 to primary completion in May 2026, 2 months.
Of 1,104 non-industry interventional studies with no phase under Prostatic Neoplasms, half reached primary completion within 43 months of starting (the median), counting those still running; a quarter within 22 and three quarters within 87. This study's 2 months is below that.
Counting every sponsor, half of 1,162 studies reached it within 43 months; a quarter within 22 and three quarters within 86.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Koc University Hospital